Abcam Plc (ABC) to Issue Dividend of GBX 7.36 on December 8th
Abcam Plc (LON:ABC) declared a dividend on Monday, September 11th, Upcoming.Co.Uk reports. Stockholders of record on Thursday, November 16th will be paid a dividend of GBX 7.36 ($0.10) per share on Friday, December 8th. This represents a dividend yield of 0.71%. The ex-dividend date is Thursday, November 16th. This is a positive change from Abcam Plc’s previous dividend of $2.83. The official announcement can be accessed at this link.
Abcam Plc (ABC) opened at GBX 961.50 ($12.65) on Wednesday. Abcam Plc has a 1-year low of GBX 759.50 ($9.99) and a 1-year high of GBX 1,113 ($14.64).
In other Abcam Plc news, insider Jonathan Simon Milner sold 567,033 shares of the stock in a transaction that occurred on Thursday, September 21st. The stock was sold at an average price of GBX 1,017 ($13.38), for a total transaction of £5,766,725.61 ($7,584,802.85). Also, insider Louise Patten purchased 1,636 shares of the stock in a transaction on Thursday, September 14th. The shares were acquired at an average price of GBX 1,079 ($14.19) per share, for a total transaction of £17,652.44 ($23,217.73).
Several analysts recently commented on the company. Peel Hunt reaffirmed a “hold” rating and set a GBX 750 ($9.86) target price on shares of Abcam Plc in a report on Friday, August 18th. Berenberg Bank reaffirmed a “buy” rating and set a GBX 1,100 ($14.47) target price on shares of Abcam Plc in a report on Monday, September 11th. Panmure Gordon reaffirmed a “sell” rating on shares of Abcam Plc in a report on Monday, September 11th. Numis Securities Ltd raised their target price on Abcam Plc from GBX 1,116 ($14.68) to GBX 1,200 ($15.78) and gave the stock an “add” rating in a report on Tuesday, September 12th. Finally, J P Morgan Chase & Co reaffirmed a “neutral” rating and set a GBX 864 ($11.36) target price on shares of Abcam Plc in a report on Tuesday, September 12th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of GBX 972.67 ($12.79).
Abcam Plc Company Profile
Abcam plc is a global life sciences company. As a developer of reagents and tools, the Company’s purpose is to serve life science researchers globally. Providing the research and clinical communities with tools and scientific support, the Company offers validated biological binders and assays to address important targets in critical biological pathways.
Receive News & Stock Ratings for Abcam Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam Plc and related stocks with our FREE daily email newsletter.